The push for better COVID-19 vaccines and treatment

The RINJ Foundation is once again urging for better vaccine and jabs for all persons in all countries. Is a global consortium possible?

The newest DMAbs approach currently in clinical trials, for example, by a team that is comprised of institutions and the pharmaceutical AstraZeneca shows promise for treating existing COVID-19 as well as preventing infection.  AstraZenica from the outset of the pandemic produced its COVID-19 vaccine as a nonprofit venture for a limited time, to July 2021, earning tons of credibility.

“The vaccination gambit is on a wrong track. On accounting evidence profit is the goal. Preventing infection should be the new goal.” urges The RINJ Foundation.

“I believe there is a need for a smarter SARS2 vaccine that can be an RNA or DNA messenger for inner structure data of the SARS-CoV-2 virus to human cells & forget the dynamically changing spike protein ID which is the virus’s method for grabbing human cells. With precise ID of the deep structure of the virus, a DNA vaccine to teach immune system cells to identify & suppress the virus at its core, not just block spike proteins which disguise often, a vaccine should and could prevent against COVID infection.” Citing The RINJ Foundation CEO: “Civil society wants better and more COVID vaccine to prevent infection for everyone”

Despite many vaccines in use, COVID-19 is still a mass murderer

“Despite all of the progress made on COVID-19 treatments and management, this disease continues to kill three times more Americans than the flu. We need better methods to prevent complications of this disease particularly in immunocompromised patients. Our study will test a new way to deliver antibodies against COVID-19 that have been proven to decrease hospitalizations and deaths from this terrible disease,” says Pablo Tebas, MD, Professor of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania.

But the Women’s safety and human rights group wants disease prevention for all.

“When the pharmaceuticals realized their vaccines would be behind the evolution of the novel zoonotic SARS-CoV-2, they began promoting the fact that their vaccines prevent more serious outcomes. Still people died in massive numbers despite the vaccines saving millions of lives,” explains Dr. Nassima al Amouri, medical director of The RINJ Foundation.

“Yes, the early vaccines saved tens of millions of lives according to all the biostatisticians I have read or talked with, but now, while expressing gratitude for the early vaccines, RINJ Women and civil society partners are urging world scientists to do even better and work at coming up with a vaccine that prevents any infection by the COVID-19-causing SARS-CoV-2,” Dr. al Amouri added.

“Instead of the competitive hustle to make profits, by pharmaceuticals, the world needs a valid human-development-oriented consortium, perhaps under the oversight of the World Health Organization, to oversee production and distribution of vaccines. It could be the contractor and the lead research and development center point,” added Dr. Nassima al Amouri.


“Get vaccinated and boosted and wear a fit-tested respirator mask or the best mask one can afford until a vaccine that totally prevents infection is available.”

 “We are saying thanks for the excellent early vaccines that saved so many lives, and we are saying we want more, even better vaccines, and better treatments, and are willing to help muster up volunteers for clinical trials, and whatever additional help we can provide, around the world,” said Dr. Nassima al Amouri.


Experts say, BA.5 is here, mask up

While expressing gratitude for early COVID vaccines, RINJ Women and civil society partners urge scientists to do even better, a vaccine that prevents SARS-CoV-2  infection. Meanwhile, The Nurses Without Borders, a RINJ Foundation subgroup urges families to mask up with N95 Respirators. Photo Credit: Micheal John /